Tokyo-headquartered biopharma Sosei Heptares (TSE:4565) announced that it had won Licensing Deal of the Year and Executive of the Year at the inaugural Informa Pharma Intelligence Awards Japan. A panel of experts from academia and business across Japan judged the awards series. The judges selected Sosei Heptares’ potentially multibillion-dollar alliance with San Diego, California–based Neurocrine…